A. Martínez Vea

Adjustment of Eculizumab Dosage Pattern in Patients with Atypical Hemolytic Uremic Syndrome with Suboptimal Response to Standard Treatment Pattern

B. Quiroga, F. de Álvaro Moreno, C. García Monteavaro, 2016, Case reports in nephrology.

Increase in serum potassium caused by beta-2 adrenergic blockade in terminal renal failure: absence of mediation by insulin or aldosterone.

J. Montoliu, P. Arrizabalaga, L. Revert, 1983, Proceedings of the European Dialysis and Transplant Association. European Dialysis and Transplant Association.

[Proteinuria in the nephrotic range as the initial manifestation of polycystic kidney].

J. A. Oliver, A. Martínez Vea, C. Richard, 1985, Medicina clinica.

Renal tubular acidosis with an elevated anion gap in a 'glue sniffer'.

A. Martínez Vea, J. S. Sarmiento Martínez, J. J. Guardiola Sala, 1989, Human toxicology.

Minimal-change glomerulopathy associated with diclofenac: response to prednisone.

A. Martínez Vea, C. García Ruiz, J. A. Rotellar, 1989, American Journal of Kidney Diseases.

[Malignant retroperitoneal fibrosis associated with pulmonary carcinoma. A review of the literature (author's transl)].

O. Ferrer-Roca, L. Revert, A. Darnell, 1982, Medicina clínica (Ed. impresa).

[Is there a relationship between cystatin C and inflammatory status, oxidative stress and other cardiovascular risk factors in non-diabetic patients with chronic kidney disease?].

A. Bardají, C. Gutiérrez, J. Marsillach, 2009, Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia.

Hepatic infarction: an unusual complication of nephrotic syndrome in a patient with diabetes mellitus.

E. Mayayo Artal, A. Martínez Vea, C. García Ruiz, 1990, Postgraduate medical journal.